Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Erythromycin stearate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Erythromycin stearate 250mg tablets
0501050N0AAAAAA
|
Erythromycin stearate | Erythromycin stearate | Infections | 914 |
|
Erythromycin stearate 500mg tablets
0501050N0AAABAB
|
Erythromycin stearate | Erythromycin stearate | Infections | 794 |
|
Erythrocin 250 tablets
0501050N0BBAAAA
|
Erythrocin (Systemic) | Erythromycin stearate | Infections | 204 |
|
Erythrocin 500 tablets
0501050N0BBABAB
|
Erythrocin (Systemic) | Erythromycin stearate | Infections | 125 |
|
Erythrolar 250mg tablets
0501050N0BCAAAA
|
Erythrolar (Tablet) | Erythromycin stearate | Infections | No data available |
|
Erythrolar 500mg tablets
0501050N0BCABAB
|
Erythrolar (Tablet) | Erythromycin stearate | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.